Our hybrid clinic, being part animal hospital and part cryonics facility, enables us to perform cryopreservation directly after euthanasia.
This allows us to achieve lab-quality cryopreservation for pets, something we cannot yet get with humans.
Our procedures can vary greatly depending on species, breed, size, and medical state of pets.
Our procedure begins only after clinical death of the pet once they've reached the end of their natural lives. In ideal cases, this is directly following euthanasia, avoiding ischemic damage and allowing for lab-quality cryopreservation. In the case of sudden, unexpected death, we offer emergency kits to stabilize your pet and prevent as much damage as possible. To begin the process, we administer multiple medications to aid in the cryopreservation procedure and prevent clotting. We place the pet in an ice-water mixture to start to cool down the body.
Next we begin perfusing the brain and body with cryoprotectants, which are a sort of medical-grade anti-freeze. This is done via aortic cannulation using a perfusion circuit. As we continue to cool the pet down, higher concentrations of cryoprotectants are perfused until the concentration is high enough for vitrification, ensuring we form a glass-like substance instead of ice crystals. This is vital, considering ice formation crushes cells and exposes them to lethal concentrations of salt.
The final temperature the pet will reach after being cooled down further is -196° C. At this temperature biology is halted. We use slow cooling to prevent thermal stress, mitigating fractures. Depending on the size of the pet, this can take days or weeks. Pets are safely secured in cryogenic dewars that are periodically topped-off with liquid nitrogen to maintain their temperature, and kept there for the long-term until revival. This means pets will maintain their temperature even if there is a power outage.
We’re pushing the science forward in whole-body cryopreservation. Below are some of our interest areas we’ll be exploring on the research end in the coming years.
Cryoprotectants are used to protect cells, tissues, and organs from the damaging effects of freezing and dehydration, but are, themselves, toxic. Our research will look into engineering new types of cryoprotectants to prevent more damage and allow for easier revival in the future.
Storing vitrified pets at -196° C enables safe, affordable long-term storage using liquid nitrogen, not electricity. Intermediate temperature storage, around -130° C, may allow for easier revival due to less fractures, but comes with obstacles in affordability and power failure risk. Our research will look into ways around these obstacles to allow for this option.
Although ideal cases begin directly after euthanasia, sometimes sudden and unexpected death occurs. Our research will include sourcing and manufacturing the necessary items to develop emergency stabilization kits, allowing pet owners to prevent as much damage as possible.
After ensuring we can get the best possible preservation of our pet's brains and bodies, our next priority is working towards repair and revival. Our research in this area will look into rewarming and re-perfusion protocols for whole bodies and investigating the revival technologies needed for pets cryopreserved today such as conventional cell repair and molecular reconstruction.
As of today, there are not standardized whole-body cryopreservation procedures that are used across multiple cryonics providers. We aim to develop standardized procedures verified by 3rd party neuroscience foundations and performed only by Doctors of Veterinary Medicine. We aim to carefully log every suspension and have transparent quality assurance.
There are certain types of tissues, such as skeletal muscle tissue and fatty tissues, that don't cryopreserve as well as others. Our research will include isolated experiments in cryopreservation of these tissues as well as applied research in improving procedures for whole-body cryopreservation cases.
Arigos Biomedical pioneered the persufflation cryopreservation work and were able to recover pig hearts from -120° C. Persufflation enabled the organs to be cooled much faster, allowing for less cryoprotectants to be used, and protected against thermal stresses. Our research will look into persufflation applications on whole-body specimens.
Although sudden death cases are much more rare in pets than in humans, it would be ideal to be prepared for all possibilities. Our research will look into building what we call a Sudden Death Augment (SDA) which will be a surgically implanted device that could take measures to automatically stabilize and cool down bodies in the event of unexpected death.